Lv4
430 积分 2021-04-27 加入
Defining immune reset: achieving sustained remission in autoimmune diseases
15天前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
17天前
已完结
Surface phenotypes of naive and memory B cells in mouse and human tissues
2个月前
已完结
Depletion of B Cells in Murine Lupus: Efficacy and Resistance
2个月前
已完结
AB1034 CHARACTERIZATION OF RO7507062, A CD19-TARGETING T-CELL BISPECIFIC ANTIBODY (CD19TCB), AND DESIGN OF A PHASE 1 TRIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS
2个月前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
2个月前
已完结
FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis
3个月前
已完结
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
3个月前
已完结
Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies
3个月前
已完结
Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA‐Approved Bispecific Antibodies in Oncology
4个月前
已完结
皖公网安备34019202002308
